Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 21233412)

1.

IFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation.

Gujer C, Sandgren KJ, Douagi I, Adams WC, Sundling C, Smed-Sörensen A, Seder RA, Karlsson Hedestam GB, Loré K.

J Leukoc Biol. 2011 Jun;89(6):811-21. doi: 10.1189/jlb.0810460. Epub 2011 Jan 13.

2.

IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells.

de Groen RA, Groothuismink ZM, Liu BS, Boonstra A.

J Leukoc Biol. 2015 Jun 30. pii: jlb.3A0215-041RR. [Epub ahead of print]

PMID:
26130701
3.

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.

Traitanon O, Mathew JM, La Monica G, Xu L, Mas V, Gallon L.

PLoS One. 2015 Jun 18;10(6):e0129658. doi: 10.1371/journal.pone.0129658. eCollection 2015.

4.

Human proximal tubule epithelial cells modulate autologous B cell function.

Sampangi S, Wang X, Beagley KW, Klein T, Afrin S, Healy H, Wilkinson R, Kassianos AJ.

Nephrol Dial Transplant. 2015 Jun 8. pii: gfv242. [Epub ahead of print]

PMID:
26058593
5.

B cells responses and cytokine production are regulated by their immune microenvironment.

Vazquez MI, Catalan-Dibene J, Zlotnik A.

Cytokine. 2015 Aug;74(2):318-26. doi: 10.1016/j.cyto.2015.02.007. Epub 2015 Mar 2. Review.

PMID:
25742773
6.

TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.

Simchoni N, Cunningham-Rundles C.

J Immunol. 2015 Apr 1;194(7):3035-44. doi: 10.4049/jimmunol.1402690. Epub 2015 Mar 4.

PMID:
25740945
7.

Human pDCs preferentially sense enveloped hepatitis A virions.

Feng Z, Li Y, McKnight KL, Hensley L, Lanford RE, Walker CM, Lemon SM.

J Clin Invest. 2015 Jan;125(1):169-76. doi: 10.1172/JCI77527. Epub 2014 Nov 21.

8.

Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells.

Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyó JM, Weimar W, Betjes MG, Baan CC, Hoogduijn MJ.

Stem Cells. 2015 Mar;33(3):880-91. doi: 10.1002/stem.1881.

PMID:
25376628
9.

Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells.

Pazmandi K, Agod Z, Kumar BV, Szabo A, Fekete T, Sogor V, Veres A, Boldogh I, Rajnavolgyi E, Lanyi A, Bacsi A.

Free Radic Biol Med. 2014 Dec;77:281-90. doi: 10.1016/j.freeradbiomed.2014.09.028. Epub 2014 Oct 7.

PMID:
25301097
10.

Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.

Boor PP, Metselaar HJ, Mancham S, van der Laan LJ, Kwekkeboom J.

Clin Exp Immunol. 2013 Dec;174(3):389-401. doi: 10.1111/cei.12191.

11.

Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.

Ngaotepprutaram T, Kaplan BL, Carney S, Crawford R, Kaminski NE.

Toxicology. 2013 Aug 9;310:84-91. doi: 10.1016/j.tox.2013.05.009. Epub 2013 May 29.

12.

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.

Matthews K, Chung NP, Klasse PJ, Moutaftsi M, Carter D, Salazar AM, Reed SG, Sanders RW, Moore JP.

PLoS One. 2013 May 20;8(5):e63785. doi: 10.1371/journal.pone.0063785. Print 2013.

13.

Dual role of CpG-stimulated B cells in the regulation of dendritic cells: comment on the article by Berggren et al.

Maddur MS, Kaveri SV, Bayry J.

Arthritis Rheum. 2013 Aug;65(8):2215-6. doi: 10.1002/art.38004. No abstract available.

14.

Reply: To PMID 22736048.

Eloranta ML, Rönnblom L.

Arthritis Rheum. 2013 Aug;65(8):2216. doi: 10.1002/art.38003. No abstract available.

15.

Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.

Deal EM, Lahl K, Narváez CF, Butcher EC, Greenberg HB.

J Clin Invest. 2013 Jun;123(6):2464-74. doi: 10.1172/JCI60945. Epub 2013 May 1.

16.

Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.

Guéry L, Hugues S.

Front Immunol. 2013 Mar 6;4:59. doi: 10.3389/fimmu.2013.00059. eCollection 2013.

17.

Epithelial control of the human pDC response to extracellular bacteria.

Michea P, Vargas P, Donnadieu MH, Rosemblatt M, Bono MR, Duménil G, Soumelis V.

Eur J Immunol. 2013 May;43(5):1264-73. doi: 10.1002/eji.201242990. Epub 2013 Mar 6.

PMID:
23436642
18.

Plasmacytoid dendritic cells are scarcely represented in the human gut mucosa and are not recruited to the celiac lesion.

Ráki M, Beitnes AC, Lundin KE, Jahnsen J, Jahnsen FL, Sollid LM.

Mucosal Immunol. 2013 Sep;6(5):985-92. doi: 10.1038/mi.2012.136. Epub 2013 Jan 23.

PMID:
23340820
19.

Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation.

Matthews K, Chung NP, Klasse PJ, Moore JP, Sanders RW.

J Immunol. 2012 Dec 15;189(12):5729-44. doi: 10.4049/jimmunol.1200601. Epub 2012 Nov 16.

20.

Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.

Ogata M, Ito T, Shimamoto K, Nakanishi T, Satsutani N, Miyamoto R, Nomura S.

Int Immunol. 2013 Mar;25(3):171-82. doi: 10.1093/intimm/dxs103. Epub 2012 Nov 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk